Does personalized medicine cut the mustard when it comes to treating cancer? Richard Smith, a former editor of the British Medical Journal, believes that it does not. Using the mustard metaphor, he shows how personalized medicine undermines the pharmaceutical industry’s profits. If the one-size-fits-all approach to prescribing cancer drugs were abandoned, drug companies would be forced to change their business model, most notably by increasing prices radically – or stop producing the drugs altogether.
View the original article here: Personalized Medicine’s Perverse Economics
Personalized medicine’s perverse economics
Donna Dickenson | Project Syndicate | December 21, 2012
{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
Infographics | More... |
Are pesticide residues on food something to worry about?
In 1962, Rachel Carson’s Silent Spring drew attention to pesticides and their possible dangers to humans, birds, mammals and the ...
Most Popular
- Is tilapia a human-made freak that we should avoid — or an evolutionary rockstar?
- Viewpoint: The organic food industry is a $180 billion marketing fraud
- Avian flu virus detected in raw milk from infected dairy cows. Are we in danger of it spreading to our food supply?
- Don’t believe the hype: Organic produce is not healthier than conventionally-grown fruit and vegetables
- Viewpoint: ‘If we follow science, organic food loses its apparent advantages’ — Harvard professor debunks organic produce myths
- Rollout of Vitamin A enhanced GMO Golden Rice in the Philippines blocked by surprise court ruling
- Climate change agriculture: GM crops, no-till farming and judicious use of glyphosate and other herbicides help address disruptions, Canadian study finds
- How IARC and other ‘independent’ global cancer assessment agencies can distort the public’s understanding of the risks of cancer
- Infographic: Pathway of human evolution, from protocells to people
- Dissecting claims about Monsanto suing farmers for accidentally planting patented seeds